Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Letter

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

          
Total article views   Abstract views HTML views PDF downloads Totals
6,741 Dovepress* 5,506 413+ 1,694 5,919
PubMed Central* 0 822 263 822
Totals 5,506 1,235 1,957 6,741
*Since 25 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar